← All trials
NCT04303390
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 6, 2018
- Primary completion
- Aug 5, 2021
- Completion date
- Dec 31, 2021
- First posted
- Mar 11, 2020
- Last posted
- Mar 11, 2020
- Enrollment
- 520
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Saud Al Babtain Cardiac CenterLead sponsor
- Saud Al Babtain Cardiac CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.